Rallybio
在场
Rallybio 是一家在股票代码 RLYB (US) 下上市的公司。
高管
查看带有其 32 名主要高管的组织结构图
Rallybio 搜索最多的简介
- Stephen Uden, President, Chief Executive Officer and Director
- Martin Mackay, Executive Chairman of the Board
- Lucian Iancovici, Director
创建提醒
跟踪 Rallybio 的高管变动
生物技术
Rallybio 拥有 2,335 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Visus Therapeutics and Tenpoint Therapeutics have merged (公布2024十二月27号)..
- Deerfield has announced the acquisition of Singular Genomics (公布2024十二月24号).
- Aadi Bioscience 刚刚宣布为 100 筹款数百万美元。 (公布2024十二月20号).
生物技术 行业的其他推荐联系人
消息
Rallybio 的最新新闻稿
- Newsroom | Page 2 | Rallybio
- Newsroom | Page 3 | Rallybio
- Rallybio Announces Clinical Proof of Concept for RLYB211, an Anti-HPA-1a Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) | Rallybio
- Rallybio Reveals Details of Two Pipeline Programs with the Potential to Transform the Lives of Patients with Rare Diseases | Rallybio
- Steven Tuch Joins Rallybio to Lead Corporate Development | Rallybio
- Rallybio to Present at the 3rd Annual Evercore ISI HealthCONx Conference | Rallybio
- Rallybio Announces First-in-Human Dosing in RLYB211 Phase 1/2 Study | Rallybio
- Rallybio to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference | Rallybio
- View more press releases Close
通过电子邮件
